コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 who exhibited airway wall thickening without airway narrowing.
2 erapeutic target in CF and other diseases of airway narrowing.
3 ; in allergic mice, gVPLA2 caused persistent airway narrowing.
4 nges in enhanced pause (Penh) as an index of airway narrowing.
5 MCh challenge are associated with conducting airway narrowing.
6 ilies also suggests a propensity for dynamic airway narrowing.
7 e hyperreactive to stimuli causing extensive airway narrowing.
8 nflammatory disease associated with episodic airway narrowing.
9 ic disease characterized by life-threatening airway narrowing.
10 n of integrin alpha9beta1 increased in vitro airway narrowing and airway smooth muscle contraction in
13 ctively structural abnormalities involved in airway narrowing and bronchial reactivity, particularly
14 ubjects, asthmatics have (1) more collateral airway narrowing and closure and lower segmental complia
15 truct, to our knowledge, a new model wherein airway narrowing and closure dynamics are modulated by c
17 eveloped a method to simultaneously quantify airway narrowing and muscle shortening using 2-photon mi
20 cked fully gVPLA2-induced cell migration and airway narrowing as marked by reduction of migrating leu
21 simulate the impact of different degrees of airway narrowing at different levels of the airway tree
23 , co-activation produced volume compression (airway narrowing) at large airway volumes (P < 0.05), bu
25 of nonspecific agonists and that the induced airway narrowing can be reversed by the inhalation of a
26 duals develop this condition, the associated airway narrowing can materially interfere with performan
27 steinyl leukotrienes are potent mediators of airway narrowing derived from the lipoxygenation of arac
30 nge during sleep, related to transient upper airway narrowing disrupting ventilation, and causing oxy
32 arrowing in the small airways and that small airway narrowing has a marked impact on both asthma cont
34 f beta2AR-selective PAMs in the treatment of airway narrowing in asthma and other obstructive respira
35 s naturally to the suggestion that excessive airway narrowing in asthma may be associated with the de
36 d oscillation R5 - R20 as a measure of small airway narrowing in asthma, and to investigate the role
37 cluding cough, and are a potent stimulus for airway narrowing in asthmatic patients, but the mechanis
49 l area, particularly during inspiration; (2) airway narrowing occurred during inspiration without evi
50 els were used to predict the impact on small airway narrowing of type-2 targeting biologics using poo
51 rt (n = 177) to simulate the impact of small airway narrowing on asthma control and quality of life.
53 symptoms and the demonstration of reversible airways narrowing on lung function testing, which is dif
54 nd (2) after challenge, increased collateral airway narrowing or closure without a change in complian
55 ation is not correlated with the severity of airway narrowing or the severity of bronchial hyperrespo
56 thma, and to investigate the role that small airway narrowing plays in asthma.Methods: Patient-based
57 rs, we categorized subjects into predominant airway narrowing [positive (SA/V) more than 0] and predo
58 rrent knowledge about ASM and its effects on airway narrowing, remodeling, and inflammation in asthma
60 e pooled trials equated to a predicted small airway narrowing reversal of approximately 40%.Conclusio
62 ed bronchoconstriction (EIB) describes acute airway narrowing that occurs as a result of exercise.
63 ion has been postulated to contribute to the airway narrowing that occurs following exercise or hyper
65 ary disease and asthma by 1) contributing to airway narrowing through hyperplasia and hypertrophy and
67 ogically and by differential cell count, and airway narrowing was measured by calibrated micrometry.
68 these changes include sputum production and airway narrowing, which lead to asthma exacerbations.
69 airways hyperresponsiveness; and (3) distal airway narrowing, which may be associated with histopath
70 phase reaction (EPR), that leads to maximal airway narrowing within 15-30 min, followed by a recover
71 inhibition of a2B1 mitigated IL-13-enhanced airway narrowing without altering muscle shortening by i